Lo Ted S N, Buch Ashesh N, Hall Ian R, Hildick-Smith David J, Nolan James
Cardiothoracic Centre, University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom.
J Interv Cardiol. 2006 Jun;19(3):258-63. doi: 10.1111/j.1540-8183.2006.00139.x.
Stopping oral anticoagulants prior to cardiac catheterization is associated with an increased risk of thromboembolism. Performing the procedures via the femoral artery and vein without interruption of anticoagulation is associated with a high rate of major access site complications. The transradial technique for left heart catheterization is safe in fully anticoagulated patients but few data are available on the percutaneous right and left heart catheterization utilizing a combination of the radial artery and antecubital vein in this group of patients.
We report our experience in 28 consecutive patients that underwent left and right heart catheterizations via this percutaneous arm approach without interruption of anticoagulation. These were compared to 31 consecutive non-anticoagulated patients that underwent the procedure via a conventional femoral artery and vein approach.
Arterial and venous accesses were achieved and complete angiographic and hemodynamic data obtained in all patients. There were no access site complications in the anticoagulated patients despite an International normalized ratio (INR) of 2.5 +/- 0.5. Procedural duration was longer in the anticoagulated group of patients, but fluoroscopy time and patient radiation dose were similar in both groups.
Our experience suggests that left and right heart catheterization can be safely performed in most fully anticoagulated patients using this technique with a low bleeding and thromboembolic risk and no increase in radiation exposure.
在心脏导管插入术前停用口服抗凝剂与血栓栓塞风险增加相关。经股动脉和静脉进行操作且不中断抗凝治疗与主要穿刺部位并发症的高发生率相关。经桡动脉技术用于左心导管插入术在完全抗凝的患者中是安全的,但关于在这类患者中联合使用桡动脉和肘前静脉进行经皮左右心导管插入术的数据较少。
我们报告了连续28例患者通过这种经皮手臂途径进行左右心导管插入术且不中断抗凝治疗的经验。将这些患者与连续31例通过传统股动脉和静脉途径进行该操作的非抗凝患者进行比较。
所有患者均成功实现动脉和静脉穿刺,并获得了完整的血管造影和血流动力学数据。尽管国际标准化比值(INR)为2.5±0.5,但抗凝患者中未出现穿刺部位并发症。抗凝组患者的操作时间较长,但两组的透视时间和患者辐射剂量相似。
我们的经验表明,使用该技术在大多数完全抗凝的患者中可以安全地进行左右心导管插入术,出血和血栓栓塞风险低,且不会增加辐射暴露。